google-site-verification: google28f501b00d980d5f.html BRAVECTO PLUS Receives New Licence to Treat Ear Mites on Cats - Vetpol Community

Announcement

Collapse
No announcement yet.

BRAVECTO PLUS Receives New Licence to Treat Ear Mites on Cats

Collapse
X
Collapse
  •  

  • BRAVECTO PLUS Receives New Licence to Treat Ear Mites on Cats

    Click image for larger version

Name:	Bravecto Plus Ear Mites Licence.jpg
Views:	338
Size:	2.01 MB
ID:	50515

    BRAVECTO PLUS®, from MSD Animal Health, has received a new licence to treat Otodectes Cynotis (Ear Mites) on cats. Studies using BRAVECTO PLUS have shown no visible signs of mites at 14 days and 100% efficacy confirmed at 28 days1. This means that BRAVECTO PLUS now offers 12 week control of fleas and ticks, eight week prevention of heartworm disease, treatment of roundworm and hookworm, and treatment of ear mites.

    Hannah Newbury, Companion Animal Technical Lead at MSD Animal Health comments: “With 1 in 4 cats in the Big Flea Project study having fleas2, we can conclude that pet owner compliance to parasite prevention is currently poor. This new licence is an important development for vets and cat owners, offering greater convenience, while helping improve flea and tick compliance. BRAVECTO PLUS builds on the qualities of BRAVECTO® and offers vets and cat owners another tool in the fight against an even broader range of potentially harmful parasites. Research by MSD Animal Health shows that 82% of cat owners believe that the ideal flea and tick treatment lasts longer than 2 months3 and vets can offer their cat owners this and more with BRAVECTO PLUS due to its 12 week duration of activity4.

    MSD Animal Health is dedicated to research and innovation, with over 70 published studies not only proving the efficacy and safety of BRAVECTO but also scientifically contributing to the industry’s knowledge and understanding of parasites.

    For vets wanting further information contact your MSD Animal Health Account Manager.

    1 Abdullah et al. Parasites & Vectors 2019; Pathogens in fleas collected from cats and dogs: distribution and prevalence in the UK.
    2 Taenzler et al. Parasites & Vectors 2018; Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats. 11:595.
    3 Transdermal Bravecto Market Assessment Study, July 2015.
    4 Bravecto Plus summary of product characteristics (SPC).
      Posting comments is disabled.

    Article Tags

    Collapse

    Latest Articles

    Collapse

    Working...
    X